To fight against hepatocarcinoma, the 6th leading cause of cancer death, and against the hepatitis that cause this type of cancer, Institut Mérieux is collaborating with bioMérieux and Transgene to develop cross-disciplinary R&D programs to:
Identify new diagnostic and prognostic biomarkers
Develop immunological and molecular diagnostic tests
Develop new treatments for hepatitis B using therapeutic vaccines
This work is based on several collaborations that were established through the Mérieux Research Grants and several international networks that bring together research teams from Brazil, the United States, China, Korea, Turkey, and France.